Chemical Compound
D-Streptamine, O-3-amino-3-deoxy-a-D-glucopyranosyl-(1?6)-O-[6-amino-6-deoxy-a-D-glucopyranosyl-(1?4)]-N1,N3-bis[(2S)-4-amino-2-hydroxy-1-oxobutyl]-2-deoxy-; O-3-Amino-3-deoxy-a-D-glucopyranosyl-(1?6)-O-[6-amino-6-deoxy-a-D-glucopyranosyl-(1?4)]-N1,N3-bis[(2S)-4-amino-2-hydroxy-1-oxobutyl]-2-deoxy-D-streptamine; 4-O-(3-Amino-3-deoxy-a-D-glucopyranosyl)-6-O-(6-amino-6-deoxy-a-D-glucopyranosyl)-1,3-N-bis[(2S)-4-amino-2-hydroxybutanoyl]-2-deoxy-L-streptamine; 1,3-Di-HABA Kanamycin A
CAS Registry Number
927821-99-6
Primary record
D-Streptamine, O-3-amino-3-deoxy-a-D-glucopyranosyl-(1?6)-O-[6-amino-6-deoxy-a-D-glucopyranosyl-(1?4)]-N1,N3-bis[(2S)-4-amino-2-hydroxy-1-oxobutyl]-2-deoxy-; O-3-Amino-3-deoxy-a-D-glucopyranosyl-(1?6)-O-[6-amino-6-deoxy-a-D-glucopyranosyl-(1?4)]-N1,N3-bis[(2S)-4-amino-2-hydroxy-1-oxobutyl]-2-deoxy-D-streptamine; 4-O-(3-Amino-3-deoxy-a-D-glucopyranosyl)-6-O-(6-amino-6-deoxy-a-D-glucopyranosyl)-1,3-N-bis[(2S)-4-amino-2-hydroxybutanoyl]-2-deoxy-L-streptamine; 1,3-Di-HABA Kanamycin A
- 库存
- 5,285 克
- 纯度
- 98.2 %
- CAS
- 927821-99-6
化合物标识与属性
- CAS
- 927821-99-6
- PubChem CID
- 102307373
- SMILES
- C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1NC(=O)[C@H](CCN)O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)N)O)NC(=O)[C@H](CCN)O
- Canonical SMILES
- NCC[C@H](O)C(=O)N[C@H]1C[C@@H](NC(=O)[C@@H](O)CCN)[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](N)[C@H]2O)[C@@H](O)[C@@H]1O[C@H]1O[C@H](CN)[C@@H](O)[C@H](O)[C@H]1O
名称与同义词
- Amikacin impurity B
- 1,3-Di-HABA Kanamycin A
- Amikacin EP Impurity B
- ZXG8XXK4VX
- J3.134.823D
- 927821-99-6
- (2S,2'S)-N,N'-((1S,3R,4S,5R,6R)-4-(((2S,3R,4S,5S,6R)-4-Amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-6-(((2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)-5-hydroxycyclohexane-1,3-diyl)bis(4-amino-2-hydroxybutanamide)
- (2S)-4-amino-N-[(1S,2R,3R,4S,5R)-5-[(2S)-4-amino-2-hydroxybutanamido]-4-{[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2-{[(2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-3-hydroxycyclohexyl]-2-hydroxybutanamide
- 4-Amino-N-((1R,2S,5S)-5-((S)-4-amino-2-hydroxybutanamido)-2-(((2S,4S,5S)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4-(((2R,5S)-6-(aminomethyl)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide
- 6-O-(3-Amino-3-deoxy-alpha-D-glucopyranosyl)-4-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl)-N,N -bis[(S)-4-amino-2-hydroxybutyryl]-2-deoxy-D-streptamine
- 6-O-(3-Amino-3-deoxy-alpha-D-glucopyranosyl)-4-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl)-N1,N3-bis[(S)-4-amino-2-hydroxybutyryl]-2-deoxy-D-streptamine
- D-Streptamine, O-3-amino-3-deoxy-a-D-glucopyranosyl-(1?6)-O-[6-amino-6-deoxy-a-D-glucopyranosyl-(1?4)]-N1,N3-bis[(2S)-4-amino-2-hydroxy-1-oxobutyl]-2-deoxy-; O-3-Amino-3-deoxy-a-D-glucopyranosyl-(1?6)-O-[6-amino-6-deoxy-a-D-glucopyranosyl-(1?4)]-N1,N3-bis[(2S)-4-amino-2-hydroxy-1-oxobutyl]-2-deoxy-D-streptamine; 4-O-(3-Amino-3-deoxy-a-D-glucopyranosyl)-6-O-(6-amino-6-deoxy-a-D-glucopyranosyl)-1,3-N-bis[(2S)-4-amino-2-hydroxybutanoyl]-2-deoxy-L-streptamine; 1,3-Di-HABA Kanamycin A
- D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-->6)-O-[6-amino-6-deoxy-alpha-D-glucopyranosyl-(1-->4)]-N1,N3-bis[(2S)-4-amino-2-hydroxy-1-oxobutyl]-2-deoxy-
- O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-->6)-O-[6-amino-6-deoxy-alpha-D-glucopyranosyl-(1-->4)]-N1,N3-bis[(2S)-4-amino-2-hydroxy-1-oxobutyl]-2-deoxy-D-streptamine